Utility of a Clinical Risk Factor Scoring Model in Predicting Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae on Hospital Admission

Validation of Clinical Scores for Risk Assessment

(2012) J. van Griensven et al.   CLINICAL INFECTIOUS DISEASES

Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System

(2011) Mario Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia

(2011) S. Aliberti et al.   CLINICAL INFECTIOUS DISEASES

Incidence and Antimicrobial Susceptibility of Escherichia coli and Klebsiella pneumoniae with Extended-Spectrum  -Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)

(2010) S. P. Hawser et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections

(2009) Ö.K. Azap et al.   CLINICAL MICROBIOLOGY AND INFECTION

Predictors of Mortality Among Patients With Community-Onset Infection Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli in Thailand

(2007) Anucha Apisarnthanarak et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY